Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent

Biomaterials

Volumn 33, Issue 33, 2012, Pages 8625-8631

  Liu, Lihong ^a   Huang, Yuan ^b   Riduan, Siti Nurhanna ^a   Gao, Shujun ^a   Yang, Yiyan ^a   Fan, Weimin ^b,c   Zhang, Yugen ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b ZHEJIANG UNIVERSITY   (China)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Broad spectrum antimicrobial agent; Drug resistant microbials; Haemocompatible; High in vivo efficacy; Main chain imidazolium oligomer

Indexed keywords

ANTI-MICROBIAL AGENT; HAEMOCOMPATIBLE; IMIDAZOLIUM; IN-VIVO; MICROBIALS;

BACTERIA; BIOMIMETICS; ENZYME INHIBITION;

OLIGOMERS;

ANTIINFECTIVE AGENT; BIOMIMETIC MATERIAL; FLUCONAZOLE; IMIDAZOLE DERIVATIVE; MAIN CHAIN IMIDAZOLIUM OLIGOMER MATERIAL; OLIGOMER; PENICILLIN G POTASSIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ESCHERICHIA COLI; FEMALE; FUNGICIDAL ACTIVITY; HEMAGGLUTINATION; HEMOLYSIS; IN VIVO STUDY; INFLAMMATION; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANIMALS; ANTI-INFECTIVE AGENTS; CELLS, CULTURED; CRYPTOCOCCUS NEOFORMANS; ERYTHROCYTES; HEMOLYSIS; IMIDAZOLES; KLEBSIELLA PNEUMONIAE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; RATS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

ENTEROCOCCUS; FILOBASIDIELLA NEOFORMANS; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84866159718     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.08.006     Document Type: Article

References (49)

1. Arias C.A., Murray B.E. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N Engl J Med 2009, 360:439-443.
2. Hancock R.E.W., Sahl H.G. Antimicrobial and host defense peptides as novel anti-infective therapeutic strategies. Nat Biotechnol 2006, 24:1551-1557.
3. Fernandez-Lopez S., Kim H.S., Choi E.C., Delgado M., Granja J.R., Khasanov A., et al. Antibacterial agents based on the cyclic d, l-alpha-peptide architecture. Nature 2001, 412:452-456.
4. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol 2005, 3:238-250.
5. Oren Z., Shai Y. Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. Biochemistry 2000, 39:6103-6114.
6. Radzishevsky I.S., Rotem S., Bourdetsky D., Navon-Venezia S., Carmeli Y., Mor A. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat Biotechnol 2007, 25:657-659.
7. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
8. Boman H.G. Antibacterial peptides: key components needed in immunity. Cell 1991, 65:205-207.
9. Lehrer R.I., Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 1999, 11:23-27.
10. Hoffmann J.A., Kafatos F.C., Janeway C.A.J.R., Ezekowitz R.A.B. Phylogenetic perspectives in innate immunity. Science 1999, 284:1313-1318.
11. AL-Badri Z.M., Som A., Lyon S., Nelson C.F., Nusslein K., Tew G.N. Investigating the effect of increasing charge density on the hemolytic activity of synthetic antimicrobial polymers. Biomacromolecules 2008, 9:2805-2810.
12. Ilker M.F., Nusslein K., Tew G.N., Coughlin E.B. Tuning the hemolytic and antibacterial activities of amphiphilic polynorbornene derivatives. J Am Chem Soc 2004, 126:15870-15875.
13. Ivanov I., Vemparala S., Pophristic V., Kuroda K., DeGrado W.F., McCammon J.A., et al. Characterization of nonbiological antimicrobial polymers in aqueous solution and at water-lipid interfaces from all-atom molecular dynamics. J Am Chem Soc 2006, 128:1778-1779.
14. Tew G.N., Liu D., Chen B., Doerksen R.J., Kaplan J., Carroll P.J., et al. De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci USA 2002, 99:5110-5114.
15. Haldar J., An D., De Cienfuegos L.A., Chen J., Klibanov A.M. Polymeric coatings that inactivate both influenza virus and pathogenic bacteria. Proc Natl Acad Sci USA 2006, 103:17667-17671.
16. Tew G.N., Scott R.W., Klein M.L., DeGrado W.F. De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications. Acc Chem Res 2010, 43:30-39.
17. Kenawy E.R., Worley S.D., Broughton R. The chemistry and applications of antimicrobial polymers: a state-of-the-art review. Biomacromolecules 2007, 8:1359-1384.
18. Li P., Poon Y.F., Li W., Zhu H.Y., Yeap S.H., Cao Y., et al. A polycationic antimicrobial and biocompatible hydrogel with microbe membrane suctioning ability. Nat Mater 2011, 10:149-156.
19. Wang J., Chen Y., Yao K., Wilbon P., Zhang W., Ren L., et al. Robust antimicrobial compounds and polymers derived from natural resin acids. Chem Commun 2012, 48:916-918.
20. Tashiro T. Antibacterial and bacterium adsorbing macromolecules. Macromol Macromol Mater Eng 2001, 286:63-87.
21. Li G.J., Shen J.R., Zhu Y.L. Study of pyridinium-type functional polymers. II. Antibacterial activity of soluble pyridinium-type polymers. J Appl Polym Sci 1998, 67:1761-1768.
22. Kuroda K., DeGrado W.F. Amphiphilic polymethacrylate derivatives as antimicrobial agents. J Am Chem Soc 2005, 127:4128-4129.
23. Mowery B.P., Lee S.E., Kissounko D.A., Epand R.F., Epand R.M., Weisblum B., et al. Mimicry of antimicrobial host-defense peptides by random copolymers. J Am Chem Soc 2007, 129:15474-15476.
24. Zhang C., Ding Z., Suhaimi N.A.M., Kng Y., Zhang Y.G., Zhuo L. A class of imidazolium salts is anti-oxidative and anti-fibrotic in hepatic stellate cells. Free Radic Res 2009, 43:899-912.
25. Zhao L., Zhang C., Zhuo L., Zhang Y.G., Ying J.Y. Imidazolium salts: a mild reducing and antioxidative reagent. J Am Chem Soc 2008, 130:12586-12587.
26. Huang T.W., Peng K.C., Shih H.N., Lin G.H., Chang T.F., Hsu S.J., et al. Antimicrobial properties of ethoxyether-functionalized imidazolium salts. Soft Matter 2011, 7:8392-8400.
27. Iwai N., Nakayama K., Kitazume T. Antibacterial activities of imidazolium, pyrrolidinium and piperidinium salts. Bioorg Med Chem Lett 2011, 21:1728-1730.
28. Cole M.R., Li M., El-Zahab B., Janes M.E., Hayes D., Warner I.M. Design, synthesis, and biological evaluation of β-lactam antibiotic-based imidazolium- and pyridinium-type ionic liquids. Chem Biol Drug Des 2011, 78:33-41.
29. Cornellas A., Perez L., Comelles F., Ribosa I., Manresa A., Garcia M.T. Self-aggregation and antimicrobial activity of imidazolium and pyridinium based ionic liquids in aqueous solution. J Colloid Interface Sci 2011, 355:164-171.
30. Deberelnyamba D., Kim K.S., Choi S., Park S.Y., Lee H., Kim C.J., et al. Synthesis and antimicrobial properties of imidazolium and pyrrolidinonium salts. Bioorg Med Chem 2004, 12:853-857.
31. Gopalan B., Ke Z., Zhang C., Kng Y., Suhaimi N.A.M., Riduan S.N., et al. Metal-free imidazolium salts inhibit the growth of hepatocellular carcinoma in a mouse model. Lab Invest 2011, 91:744-751.
32. Anderson E.B., Long T.E. Imidazole- and imidazolium-containing polymers for biology and material science applications. Polymer 2010, 51:2447-2454.
33. Carson L., Chau P.K.W., Earle M.J., Gilea M.A., Gilmore B.F., Gorman S.P., et al. Antibiofilm activities of 1-alkyl-3-methylimidazolium chloride ionic liquids. Green Chem 2009, 11:492-497.
34. Pernak J., Sobaszkiewicz K., Mirsha I. Anti-microbial activities of ionic liquids. Green Chem 2003, 5:52-56.
35. Docherty K.M., Kulpa C.F. Toxicity and antimicrobial activity of imidazolium and pyridinium ionic liquids. Green Chem 2005, 7:185-189.
36. Xu Z., Kim S.K., Yoon J. Revisit to imidazolium receptors for the recognition of anions: highlighted research during 2006-2009. Chem Soc Rev 2010, 39:1457-1466.
37. Kim H.N., Lee E.H., Xu Z., Kim H.E., Lee H.S., Lee J.H., et al. A pyrene-imidazolium derivative that selectively recognizes G-Quadruplex DNA. Biomaterials 2012, 33:2282-2288.
38. Zhang Y.G., Zhao L., Patra P.K., Hu D., Ying J.Y. Colloidal poly-imidazolium salts and derivatives. Nano Today 2009, 4:13-20.
39. Zhang Y.G., Ngeow K.C., Ying J.Y. The first N-heterocyclic carbene (NHC)-based nickel catalyst for C-S coupling. Org Lett 2007, 9:3495-3498.
40. Yong G., Zhang Y.G., Ying J.Y. Highly efficient catalytic system for selective production of hydroxymethylfurfural from glucose and fructose. Angew Chem Int Ed 2008, 47:9345-9347.
41. Lienkamp K., Madkour A.E., Tew G.N. Antimicrobial polymers prepared by ROMP with unprecedented selectivity: a molecular construction kit approach. J Am Chem Soc 2008, 130:9836-9843.
42. Talbot G.H., Bradley J., Edwards J.E., Gilbert D., Scheld M., Bartlett J.G. Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America. Clin Infect Dis 2006, 42:657-668.
43. Schneider T., Kruse T., Wimmer R., Wiedemann I., Sass V., Pag U., et al. Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II. Science 2010, 328:1168-1172.
44. De Nollin S., Borgers M. Scanning electron microscopy of Candida albicans after in vitro treatment with miconazole. Antimicrob Agents Chemother 1975, 7:704-711.
45. Venkataraman S., Zhang Y., Liu L., Yang Y.Y. Design, syntheses and evaluation of hemocompatible PEGylated-antimicrobial polymers with well-controlled molecular structures. Biomaterials 2010, 31:1751-1756.
46. Liu L., Xu K., Wang H., Tan J.P.K., Fan W., Venkatraman S.S., et al. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat Nanotech 2009, 4:457-463.
47. Nederberg F., Zhang Y., Tan J.P.K., Xu K., Wang H., Yang C., et al. Biodegradable nanostructures with selective lysis of microbial membranes. Nat Chem 2011, 3:409-414.
48. Sambhy V., Peterson B.R., Sen A. Antibacterial and hemolytic activities of pyridinium polymers as a function of the spatial relationship between the positive charge and the pendant alkyl tail. Angew Chem Int Ed 2008, 47:1250-1254.
49. Porter E.A., Wang X., Lee H.S., Weisblum B., Gellman S.H. Non-haemolytic β-amino-acid oligomers. Nature 2000, 404:565-568.